Brain surgery anesthesia showdown: which method uses less drug?
NCT ID NCT07377695
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two methods of giving the anesthetic remimazolam during cerebrovascular bypass surgery in people with moyamoya disease. One method uses a computer-controlled pump (TCI), the other uses manual weight-based dosing. The goal is to see which approach uses less total anesthetic. 58 adults will be randomly assigned to one of the two methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remimazolam (an anesthetic drug)
What this could lead to
If successful, this could help doctors use less anesthetic during brain surgery, potentially reducing side effects and costs.
What could go wrong
This is a small, early-stage study (58 people) focused on drug dosing, not on curing or treating moyamoya disease. Results may not apply to other surgeries or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOYAMOYA DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggi-do, 13620, South Korea